Vivo Bio Tech Limited (BOM:511509)
India
· Delayed Price · Currency is INR 27.83
+0.57 (2.09%)
At close: Apr 29, 2026
Vivo Bio Tech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 514.24 | 466.73 | 454.51 | 522.3 | 513.91 | 517.75 | Upgrade
|
| Other Revenue | - | - | 0 | - | - | -0 | Upgrade
|
| Revenue | 514.24 | 466.73 | 454.51 | 522.3 | 513.91 | 517.75 | Upgrade
|
| Revenue Growth (YoY) | 11.45% | 2.69% | -12.98% | 1.63% | -0.74% | -6.46% | Upgrade
|
| Cost of Revenue | 68.46 | 61.07 | 41.52 | 70.67 | 116.5 | 72.92 | Upgrade
|
| Gross Profit | 445.78 | 405.65 | 412.99 | 451.64 | 397.41 | 444.83 | Upgrade
|
| Selling, General & Admin | 231.67 | 200.56 | 202.09 | 236.62 | 239.27 | 268.21 | Upgrade
|
| Operating Expenses | 332.87 | 290.73 | 295 | 329.27 | 313.73 | 324.12 | Upgrade
|
| Operating Income | 112.91 | 114.93 | 118 | 122.36 | 83.67 | 120.71 | Upgrade
|
| Interest Expense | -60.54 | -75.04 | -77.78 | -76.51 | -39.93 | -35.3 | Upgrade
|
| Interest & Investment Income | 1.9 | 1.9 | 0.39 | 0.36 | 0.98 | 0.79 | Upgrade
|
| Other Non Operating Income (Expenses) | -42.42 | -0 | - | 0 | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | 11.85 | 41.78 | 40.61 | 46.21 | 44.72 | 86.2 | Upgrade
|
| Gain (Loss) on Sale of Assets | 46.15 | 46.15 | - | - | - | - | Upgrade
|
| Pretax Income | 58 | 87.93 | 40.61 | 46.21 | 44.72 | 86.2 | Upgrade
|
| Income Tax Expense | 12.84 | 15.1 | 15.34 | 19.72 | 22.71 | 29.37 | Upgrade
|
| Net Income | 45.17 | 72.83 | 25.26 | 26.49 | 22.02 | 56.82 | Upgrade
|
| Net Income to Common | 45.17 | 72.83 | 25.26 | 26.49 | 22.02 | 56.82 | Upgrade
|
| Net Income Growth | -35.07% | 188.27% | -4.64% | 20.33% | -61.26% | 27.93% | Upgrade
|
| Shares Outstanding (Basic) | 19 | 15 | 15 | 15 | 14 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 15 | 17 | 15 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | 15.62% | -8.33% | 12.53% | 4.66% | 4.44% | 5.23% | Upgrade
|
| EPS (Basic) | 2.34 | 4.76 | 1.70 | 1.79 | 1.56 | 4.23 | Upgrade
|
| EPS (Diluted) | 2.34 | 4.76 | 1.51 | 1.78 | 1.56 | 4.19 | Upgrade
|
| EPS Growth | -43.83% | 215.23% | -15.17% | 14.33% | -62.84% | 21.58% | Upgrade
|
| Free Cash Flow | - | -104.42 | 75.72 | 108.36 | -344.7 | -86.46 | Upgrade
|
| Free Cash Flow Per Share | - | -6.83 | 4.54 | 7.31 | -24.34 | -6.38 | Upgrade
|
| Gross Margin | 86.69% | 86.91% | 90.86% | 86.47% | 77.33% | 85.92% | Upgrade
|
| Operating Margin | 21.96% | 24.62% | 25.96% | 23.43% | 16.28% | 23.31% | Upgrade
|
| Profit Margin | 8.78% | 15.60% | 5.56% | 5.07% | 4.28% | 10.97% | Upgrade
|
| Free Cash Flow Margin | - | -22.37% | 16.66% | 20.75% | -67.07% | -16.70% | Upgrade
|
| EBITDA | 180.2 | 184.23 | 189.98 | 194.05 | 142.99 | 167.61 | Upgrade
|
| EBITDA Margin | 35.04% | 39.47% | 41.80% | 37.15% | 27.82% | 32.37% | Upgrade
|
| D&A For EBITDA | 67.29 | 69.3 | 71.98 | 71.68 | 59.32 | 46.9 | Upgrade
|
| EBIT | 112.91 | 114.93 | 118 | 122.36 | 83.67 | 120.71 | Upgrade
|
| EBIT Margin | 21.96% | 24.62% | 25.96% | 23.43% | 16.28% | 23.31% | Upgrade
|
| Effective Tax Rate | 22.13% | 17.18% | 37.78% | 42.67% | 50.77% | 34.08% | Upgrade
|
| Revenue as Reported | 519.88 | 514.77 | 454.9 | 522.66 | 514.89 | 518.54 | Upgrade
|
| Advertising Expenses | - | 0.39 | 2.79 | 2.8 | 1.22 | 36.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.